Raymond James Financial Inc. Takes Position in Teleflex Incorporated (NYSE:TFX)

Raymond James Financial Inc. acquired a new position in shares of Teleflex Incorporated (NYSE:TFX) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 58,108 shares of the medical technology company’s stock, valued at approximately $10,342,000. Raymond James Financial Inc. owned 0.13% of Teleflex at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently modified their holdings of TFX. HighTower Advisors LLC grew its stake in shares of Teleflex by 1.7% during the 3rd quarter. HighTower Advisors LLC now owns 3,998 shares of the medical technology company’s stock worth $986,000 after acquiring an additional 66 shares in the last quarter. Hengehold Capital Management LLC boosted its holdings in Teleflex by 7.3% during the fourth quarter. Hengehold Capital Management LLC now owns 1,289 shares of the medical technology company’s stock worth $229,000 after purchasing an additional 88 shares during the last quarter. Exchange Traded Concepts LLC grew its position in Teleflex by 38.2% in the fourth quarter. Exchange Traded Concepts LLC now owns 340 shares of the medical technology company’s stock valued at $61,000 after purchasing an additional 94 shares in the last quarter. Avior Wealth Management LLC increased its stake in Teleflex by 190.6% in the 3rd quarter. Avior Wealth Management LLC now owns 154 shares of the medical technology company’s stock valued at $38,000 after buying an additional 101 shares during the last quarter. Finally, Commerce Bank lifted its position in Teleflex by 6.2% during the 3rd quarter. Commerce Bank now owns 1,827 shares of the medical technology company’s stock worth $452,000 after buying an additional 106 shares in the last quarter. 95.62% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on the company. Morgan Stanley decreased their price objective on Teleflex from $275.00 to $191.00 and set an “overweight” rating for the company in a report on Wednesday, March 5th. Bank of America downgraded Teleflex from a “neutral” rating to an “underperform” rating and decreased their price target for the company from $235.00 to $140.00 in a research note on Tuesday, March 4th. Needham & Company LLC reiterated a “hold” rating on shares of Teleflex in a research note on Wednesday, March 12th. Royal Bank of Canada cut shares of Teleflex from an “outperform” rating to a “sector perform” rating and decreased their target price for the company from $220.00 to $155.00 in a research note on Friday, February 28th. Finally, StockNews.com downgraded shares of Teleflex from a “buy” rating to a “hold” rating in a report on Friday, February 28th. One research analyst has rated the stock with a sell rating, nine have given a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $182.63.

Teleflex Trading Up 0.1 %

TFX stock opened at $139.41 on Friday. Teleflex Incorporated has a one year low of $128.55 and a one year high of $249.91. The stock has a market cap of $6.46 billion, a price-to-earnings ratio of 27.72, a price-to-earnings-growth ratio of 1.73 and a beta of 1.21. The company has a fifty day moving average price of $163.83 and a two-hundred day moving average price of $195.11. The company has a debt-to-equity ratio of 0.37, a current ratio of 2.42 and a quick ratio of 1.39.

Teleflex (NYSE:TFX) last announced its earnings results on Thursday, February 27th. The medical technology company reported $3.89 EPS for the quarter, topping the consensus estimate of $3.86 by $0.03. The business had revenue of $795.40 million during the quarter, compared to the consensus estimate of $813.24 million. Teleflex had a net margin of 7.85% and a return on equity of 14.19%. Equities analysts anticipate that Teleflex Incorporated will post 13.98 EPS for the current year.

Teleflex Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Monday, March 17th. Stockholders of record on Friday, March 7th were given a $0.34 dividend. This represents a $1.36 annualized dividend and a dividend yield of 0.98%. The ex-dividend date of this dividend was Friday, March 7th. Teleflex’s payout ratio is 95.77%.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.